Abstract:
Objective : To determine the most effective method for early diagnosis of CMV infection in recipients of allogeneic peripheral blood stem cell transplants (allo-PBSCT).
Methods : Using MEIA, IFA, and real time FQ-PCR methods, we tested 42 patients after allo-PBSCT for CMV IgM antibody, CMV pp65 antigen and CMV DNA in blood at different time points.
Results : (1) In these 42 post-transplant patients, the percentages of cases with detectable CMV pp65 antigen (38.24%) and CMV DNA (33.82%) were higher than those of cases with detectable CMV IgM antibody (21.50%) (
P <0.05). (2) The appearance of CMV pp65 antigen and CMV DNA (75±64d, 60±50d) was observed earlier than that of CMV IgM antibody (127±73d) (
P <0.05). (3)There was a correlation between the presence of CMV reactive infection and acute graft-verse-host disease (
P < 0.05).
Conclusion : Combining IFA and real time FQ-PCR can make an accurate early diagnosis of CMV infection. CMV infection was a risk factor for the occurrence of GVHD in allo-PBSCT patients.